PETQ

PetIQ, Inc.

Consumer


Presented:03/02/2018
Price:$22.35
Cap:$0.57B
Current Price:$30.89
Cap:$0.92B

Presented

Date03/02/2018
Price$22.35
Market Cap$0.57B
Ent Value$0.37B
P/E Ratio32.56x
Book Value$5.32
Div Yield0%
Shares O/S25.67M
Ave Daily Vol203,474
Short Int22.26%

Current

Price$30.89
Market Cap$0.92B
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Domestic and International segments. The Domestic segment involves the Unites States and Canada markets. The International segment deals with Europe. It offers veterinarian-grade pet prescription medications; over-the-counter flea and tick preventatives; and health and wellness products for dogs and cats under the following brands: VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen. The company was founded on February 29, 2016 and is headquartered in Eagle, ID.

Publicly traded companies mentioned herein: PetIQ Inc (PETQ)

Highlights

The presenter is short shares of PetIQ (PETQ), a manufacturer and distributor of pet medications. The presenter sees disruption to PETQ’s business model as drug manufacturers change their distribution models, thus impacting how much margin PETQ can attain. In addition, there are new products coming to market that are replacing PETQ’s key distribution product, Frontline. The presenter thinks PETQ shares can trade down to the mid-single digit range as a large portion of PETQ’s revenue is now at risk.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.